Skip to main navigation
Skip to search
Skip to main content
Ewha Womans University Home
Home
Profiles
Research units
Projects
Research output
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Updated treatment guideline of chronic spontaneous urticaria
Joo Young Roh
Department of Dermatology
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Updated treatment guideline of chronic spontaneous urticaria'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Chronic Urticaria
100%
Omalizumab
45%
H1 Antagonist
18%
Add on Therapy
18%
Prevalence
9%
Controlled Clinical Trial
9%
Population
9%
Decision Making
9%
Dermatosis
9%
Monotherapy
9%
Histamine Antagonist
9%
Immunoglobulin G
9%
Immunoglobulin E
9%
Immunoglobulin E Receptor
9%
Immunoglobulin Antibody
9%
Immunoglobulin E Antibody
9%
Neuroscience
Omalizumab
100%
H1 Antagonist
40%
Decision-Making
20%
Antihistamines
20%
Immunoglobulin G
20%
Immunoglobulin E
20%
Immunoglobulin E Receptor
20%
Immunoglobulin E Antibody
20%
Immunoglobulin Antibody
20%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Urticaria
100%
Omalizumab
45%
Add on Therapy
18%
Histamine H1 Receptor Antagonist
18%
Controlled Clinical Trial
9%
Prevalence
9%
Skin Disease
9%
Antihistaminic Agent
9%
Immunoglobulin Antibody
9%
Immunoglobulin E
9%
Monotherapy
9%
Immunoglobulin E Antibody
9%
Immunoglobulin G
9%
Immunoglobulin E Receptor
9%